Welcome back to Team Insights, where we offer you a chance to get to know a Microbiome Insights team member on a deeper level. For our newest issue of Team Insights, we bring in a new member of our Sales Team: Lianna Marini. We're excited to welcome Lianna into the MBI team and looking forward to...
About Malcolm Kendall
Entries by Malcolm Kendall
Microbiome Conferences in 2024
May 24, 2024/by Malcolm KendallEvery year, we compile an extensive list of both in-person and online microbiome conferences from around the world. These events cover all aspects of the microbiome, from basic science, R&D, and commercialization to applications in human, animal, plant, environmental, gut, skin, oral health, and...
Team Insights: Sarah Carden
November 23, 2022/by Malcolm KendallWelcome back to Team Insights, where we offer you a chance to get to know a Microbiome Insights team member on a deeper level. For our newest issue of Team Insights, we bring in a new member of our Sales Team: Sarah Carden. We're excited to welcome Sarah into the Microbiome Insights team, and...
Happy International Women's Day from Microbiome Insights
March 8, 2019/by Malcolm KendallAt Microbiome Insights, we're proud of the women on our team who help us do what we do. It's important to us that we recruit only the best and most driven individuals -- and we are proud that more than 40% of our employees and leaders are women.
Microbiome Insights' Year in Review: 2017 by the numbers
December 20, 2017/by Malcolm KendallThis year, 2017, will go down in Microbiome Insights history as the year the company hit its stride and established itself as a leader in the microbiome testing field. The challenging work our team has been doing since we were founded in 2015 clearly paid off—as evidenced by our expanding client...
How close are microbiome-modulating therapies that target the brain? A quick overview of the evidence
November 1, 2017/by Malcolm KendallDebate exists about how soon knowledge about the gut-brain axis will bear fruit. Yet the microbiome-gut-brain axis is a hot topic of scientific investigation and several companies around the globe are actively pursuing gut microbiome therapies that focus on brain-related conditions.